The success of dupilumab, marketed by Sanofi under the name bDupixent, is evident in its remarkable (Dollor) 13 billion global sales achievement in...
Vous n'êtes pas connecté
Sanofi aims to boost competition in the atopic dermatitis market, following Dupixent's success, with new treatments like SAR444656 and amlitelimab in development.
The success of dupilumab, marketed by Sanofi under the name bDupixent, is evident in its remarkable (Dollor) 13 billion global sales achievement in...
WEDNESDAY, Jan. 22, 2025 -- Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis (AD) include erythema,...
On May 29, Delta State entered a new era of leadership as Rt. Hon. Sheriff Oborevwori was sworn in as Governor. Guided by a vision to elevate the...
By Nirmal Narayanan Foreigners can now invest in Saudi-listed companies owning real estate in Makkah and Madinah, following a landmark decision by...
Laboratorium: Russian scientists are developing a new method for identifying and treating cancers. The therapy aims to deliver medication directly to...
After indie success stories like "The Substance," "Thelma," and "Late Night With the Devil," distributors can't afford to stay conservative.
"In 2025, many of the challenges that defined the presale market in 2024 are expected to persist," said real estate sales and marketing firm MLA...
-new collaboration aims to advance LCDS 2030 THE Government of Guyana has announced a ground-breaking collaboration with The King’s Foundation and...
A new rezoning plan for the city aims to remove long-outdated barriers to building housing and to spread development across all the city’s...
Starbucks is bringing back perks like free refills for in-house customers and a condiment bar. The company is also reversing its open-door policy,...